So much speculation about multi billion dollar valuations and here we sit after an hour into the  market day and a whopping 250 shares have traded hands with our market cap not even at 1/2 a billion USD.

That's where I find looking back at Relypsa helpful....it was also languishing for months, even WITH an FDA approval for its product.  I agree about a Nasdaq listing, the sooner the better....I wonder what RLYP would have been trading at if they'd been listed in Canada and traded OTC in the US.  Its a moot point of course but I doube it would have been the $16 or so it was at a month before being bought out at $32.